Cargando…
Pharmacological FGF21 signals to glutamatergic neurons to enhance leptin action and lower body weight during obesity
OBJECTIVE: Fibroblast growth factor 21 (FGF21) is a peripherally-derived endocrine hormone that acts on the central nervous system (CNS) to regulate whole body energy homeostasis. Pharmacological administration of FGF21 promotes weight loss in obese animal models and human subjects with obesity. How...
Autores principales: | Claflin, Kristin E., Sullivan, Andrew I., Naber, Meghan C., Flippo, Kyle H., Morgan, Donald A., Neff, Tate J., Jensen-Cody, Sharon O., Zhu, Zhiyong, Zingman, Leonid V., Rahmouni, Kamal, Potthoff, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403559/ https://www.ncbi.nlm.nih.gov/pubmed/35944896 http://dx.doi.org/10.1016/j.molmet.2022.101564 |
Ejemplares similares
-
FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution
por: Flippo, Kyle H., et al.
Publicado: (2020) -
Conditional gene targeting using UCP1-Cre mice directly targets the central nervous system beyond thermogenic adipose tissues
por: Claflin, Kristin E., et al.
Publicado: (2021) -
Central FGF21 production regulates memory but not peripheral metabolism
por: Zhou, Bolu, et al.
Publicado: (2022) -
Liver Derived FGF21 Maintains Core Body Temperature During Acute Cold Exposure
por: Ameka, Magdalene, et al.
Publicado: (2019) -
Chronicles of an FGF chimera: The odyssey continues
por: Flippo, Kyle H., et al.
Publicado: (2019)